Christopher A. Lipinski

4 ta ish

Pfizer (United States)

1. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

   Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy +1

   Sharh maqola20017 iqtibos

   ABIABI:AkademIndex/2026.other.072774

2. Lead- and drug-like compounds: the rule-of-five revolution

   Christopher A. Lipinski

   Maqola20046 iqtibos

   ABIABI:AkademIndex/2026.other.072754

3. Drug-like properties and the causes of poor solubility and poor permeability

   Christopher A. Lipinski

   Sharh maqola20003 iqtibos

   ABIABI:AkademIndex/2026.other.175247

4. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

   Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy +1

   Maqola19972 iqtibos

   ABIABI:AkademIndex/2026.other.072807